Association of increased hepatic insulin clearance and change in serum triglycerides or β‐hydroxybutyrate concentration via the sodium/glucose‐cotransporter 2 inhibitor tofogliflozin-Reference-Cited by-同舟云学术

Association of increased hepatic insulin clearance and change in serum triglycerides or β‐hydroxybutyrate concentration via the sodium/glucose‐cotransporter 2 inhibitor tofogliflozin

Published:2020-02-14 Issue:6 Volume:22 Page:947-956
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Matsubayashi Yasuhiro¹,Yoshida Akihiro¹²^ORCID,Suganami Hideki³^ORCID,Osawa Taeko¹,Furukawa Kazuo¹,Suzuki Hiroshi¹,Fujihara Kazuya¹^ORCID,Tanaka Shiro⁴,Kaku Kohei⁵^ORCID,Sone Hirohito¹^ORCID

Affiliation:

1. Department of Hematology, Endocrinology and Metabolism, Faculty of Medicine Niigata University Niigata Japan

2. Kowa Company, Ltd Tokyo Japan

3. Clinical Data Science Dept. Kowa Co., Ltd. Japan

4. Department of Clinical Biostatistics, Graduate School of Medicine Kyoto University Japan

5. Kawasaki Medical School Okayama Japan

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13980